Source: TICKER REPORT

Prosensa: Prosensa Holding NV Given Average Recommendation of "Hold" by Analysts (NYSE:RNA)

Shares of Prosensa Holding NV (NYSE:RNA) have received a consensus recommendation of "Hold" from the nine ratings firms that are presently covering the company, AR Network reports. Five research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among analysts […]Prosensa Holding NV Given Average Recommendation of "Hold" by Analysts (NYSE:RNA) is a post from: Ticker ReportThe post Prosensa Holding NV Given Average Recommendation of "Hold" by Analysts (NYSE:RNA) appeared first on Ticker Report.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Hans Schikan's photo - CEO of Prosensa Therapeutics B.V.

CEO

Hans Schikan

CEO Approval Rating

73/100

Read more